From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves first treatment for all genotypes of hepatitis C in pediatric patients

from FDA

The U.S. Food and Drug Administration recently approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17. Mavyret was previously approved to treat HCV in adults in 2017. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063